Skip to main content
TipRanks
Go Ultimate75% OFF

Aytu BioScience (AYTU) Stock Statistics & Valuation Metrics

1,282 Followers

Total Valuation

Aytu BioScience has a market cap or net worth of $19.35M. The enterprise value is $33.34M.

Market Cap
$19.35M
Enterprise Value
$33.34M

Share Statistics

Aytu BioScience has 10,868,208 shares outstanding. The number of shares has decreased by -2.65% in one year.

Shares Outstanding
10,868,208
Owned by Insiders
5.14%
Owned by Institutions
32.82%

Financial Efficiency

Aytu BioScience’s return on equity (ROE) is -0.40 and return on invested capital (ROIC) is -14.19%.

Return on Equity (ROE)
-0.40
Return on Assets (ROA)
-0.14
Return on Invested Capital (ROIC)
-14.19%
Return on Capital Employed (ROCE)
-0.17
Revenue Per Employee
757.50K
Profits Per Employee
-187.53K
Employee Count
76
Asset Turnover
0.55
Inventory Turnover
3.03

Valuation Ratios

The current PE Ratio of Aytu BioScience is -1.30. Aytu BioScience’s PEG ratio is 0.03.

PE Ratio
-1.30
PS Ratio
0.34
PB Ratio
0.62
Price to FCF
5.95
Price to Operating Cash Flow
6.68
PEG Ratio
0.03

Income Statement

In the last 12 months, Aytu BioScience had revenue of 57.57M and earned -14.25M in profits. Earnings per share was -1.16.

Revenue
57.57M
Gross Profit
36.82M
Operating Income
-8.31M
Pretax Income
-14.23M
Net Income
-14.25M
EBITDA
-4.38M
Earnings Per Share (EPS)
-1.16

Cash Flow

In the last 12 months, operating cash flow was 3.28M and capital expenditures -29,000, giving a free cash flow of 3.25M billion.

Operating Cash Flow
3.28M
Free Cash Flow
3.25M
Free Cash Flow per Share
0.26

Dividends & Yields

Aytu BioScience pays an annual dividend of ―, resulting in a dividend yield of ―

Dividend Per Share
―
Dividend Yield
―
Payout Ratio
N/A
Free Cash Flow Yield
16.81%
Earnings Yield
-65.00%

Stock Price Statistics

Beta
1.91
52-Week Price Change
-13.59%
50-Day Moving Average
2.01
200-Day Moving Average
2.27
Relative Strength Index (RSI)
33.49
Average Volume (3m)
33.84K

Important Dates

Aytu BioScience upcoming earnings date is Nov 16, 2026, After Close (Not Confirmed).

Last Earnings Date
Sep 22, 2026
Next Earnings Date
Nov 16, 2026
Ex-Dividend Date
―

Financial Position

Aytu BioScience as a current ratio of 1.13, with Debt / Equity ratio of 51.33%

Current Ratio
1.13
Quick Ratio
1.00
Debt to Market Cap
0.65
Net Debt to EBITDA
1.87
Interest Coverage Ratio
4.39

Taxes

In the past 12 months, Aytu BioScience has paid -21.00K in taxes.

Income Tax
-21.00K
Effective Tax Rate
0.00

Enterprise Valuation

Aytu BioScience EV to EBITDA ratio is -1.31, with an EV/FCF ratio of 3.43.

EV to Sales
0.19
EV to EBITDA
-1.31
EV to Free Cash Flow
3.43
EV to Operating Cash Flow
3.40

Balance Sheet

Aytu BioScience has $26.31M in cash and marketable securities with $18.11M in debt, giving a net cash position of $8.20M billion.

Cash & Marketable Securities
$26.31M
Total Debt
$18.11M
Net Cash
$8.20M
Net Cash Per Share
$0.75
Tangible Book Value Per Share
-$0.50

Margins

Gross margin is 63.95%, with operating margin of -14.44%, and net profit margin of -24.76%.

Gross Margin
63.95%
Operating Margin
-14.44%
Pretax Margin
-24.72%
Net Profit Margin
-24.76%
EBITDA Margin
-14.74%
EBIT Margin
-21.43%

Analyst Forecast

The average price target for Aytu BioScience is $9.67, which is 11.43% higher than the current price. The consensus rating is Strong Buy

Price Target
$9.67
Price Target Upside
443.07% Upside
Analyst Consensus
Strong Buy
Analyst Count
3
Revenue Growth Forecast
-13.27%
EPS Growth Forecast
27.11%

Scores

Smart Score
―
AI Score
54